仟源医药(300254.SZ)股东翁占国拟减持不超3%股份

Core Viewpoint - The shareholder Weng Zhangguo of Qianyuan Pharmaceutical (300254.SZ) plans to reduce his stake in the company by up to 7.6831 million shares, representing no more than 3% of the total share capital, through centralized bidding and block trading from November 13, 2025, to February 12, 2026 [1] Summary by Category - Shareholder Actions - Weng Zhangguo intends to reduce his holdings in Qianyuan Pharmaceutical by a maximum of 7.6831 million shares [1] - The planned reduction accounts for up to 3% of the company's total share capital [1] - Timeline - The reduction is scheduled to take place between November 13, 2025, and February 12, 2026 [1] - Method of Reduction - The shares will be sold through centralized bidding and block trading methods [1]